Free Industrial News

China's Pharmaceutical Capacity Remains Strong Despite COVID-Related Downturn

China's Pharmaceutical Capacity Remains Strong Despite COVID-Related Downturn

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 239 Words
Attachment: 00001

BEIJING, CHINA--April 19, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--According to China's National Bureau of Statistics, in 2019, China's pharmaceutical capacity reached 2.769 million tons, with a year-over-year growth of 20.2%. In 2020, capacity was 2.734 million tons, a slight downturn attributed to the COVID-19 pandemic. The annual output of China's active pharmaceutical ingredients (APIs) stabilized at about 2.5 million tons.

Subscribe Now!(All Fields Required)

Standard Membership - Free